vs
Side-by-side financial comparison of HARVARD BIOSCIENCE INC (HBIO) and RIVERVIEW BANCORP INC (RVSB). Click either name above to swap in a different company.
HARVARD BIOSCIENCE INC is the larger business by last-quarter revenue ($23.7M vs $14.0M, roughly 1.7× RIVERVIEW BANCORP INC). RIVERVIEW BANCORP INC runs the higher net margin — 9.8% vs -12.0%, a 21.8% gap on every dollar of revenue. On growth, RIVERVIEW BANCORP INC posted the faster year-over-year revenue change (10.4% vs -3.3%). HARVARD BIOSCIENCE INC produced more free cash flow last quarter ($-545.0K vs $-736.0K). Over the past eight quarters, RIVERVIEW BANCORP INC's revenue compounded faster (24.6% CAGR vs -1.6%).
Harvard Bioscience is a global developer, manufacturer and marketer of life sciences equipment to support research and drug discovery. It is traded on NASDAQ under the stock symbol HBIO.
Riverview Bancorp Inc. is a U.S.-based bank holding company operating Riverview Community Bank, primarily serving the Pacific Northwest region. It offers personal and commercial banking products including savings accounts, consumer loans, mortgages, commercial lending, and small business financial solutions for retail customers and local enterprises.
HBIO vs RVSB — Head-to-Head
Income Statement — Q4 FY2025 vs Q3 FY2026
| Metric | | |
|---|---|---|
| Revenue | $23.7M | $14.0M |
| Net Profit | $-2.8M | $1.4M |
| Gross Margin | 59.7% | — |
| Operating Margin | 7.2% | 12.4% |
| Net Margin | -12.0% | 9.8% |
| Revenue YoY | -3.3% | 10.4% |
| Net Profit YoY | -15916.7% | 11.8% |
| EPS (diluted) | $-0.06 | $0.07 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $23.7M | $14.0M | ||
| Q3 25 | $20.6M | $13.6M | ||
| Q2 25 | $20.4M | $13.3M | ||
| Q1 25 | $21.8M | $12.9M | ||
| Q4 24 | $24.6M | $12.7M | ||
| Q3 24 | $22.0M | $12.8M | ||
| Q2 24 | $23.1M | $12.2M | ||
| Q1 24 | $24.5M | $9.0M |
| Q4 25 | $-2.8M | $1.4M | ||
| Q3 25 | $-1.2M | $1.1M | ||
| Q2 25 | $-2.3M | $1.2M | ||
| Q1 25 | $-50.3M | $1.1M | ||
| Q4 24 | $18.0K | $1.2M | ||
| Q3 24 | $-4.8M | $1.6M | ||
| Q2 24 | $-2.9M | $966.0K | ||
| Q1 24 | $-4.7M | $-3.0M |
| Q4 25 | 59.7% | — | ||
| Q3 25 | 58.4% | — | ||
| Q2 25 | 56.4% | — | ||
| Q1 25 | 56.0% | — | ||
| Q4 24 | 57.1% | — | ||
| Q3 24 | 58.1% | — | ||
| Q2 24 | 57.2% | — | ||
| Q1 24 | 60.3% | — |
| Q4 25 | 7.2% | 12.4% | ||
| Q3 25 | 1.0% | 10.2% | ||
| Q2 25 | -4.0% | 11.7% | ||
| Q1 25 | -228.1% | 11.3% | ||
| Q4 24 | 0.0% | 12.4% | ||
| Q3 24 | -8.5% | 15.5% | ||
| Q2 24 | -9.0% | 10.0% | ||
| Q1 24 | -9.3% | -47.5% |
| Q4 25 | -12.0% | 9.8% | ||
| Q3 25 | -6.0% | 8.1% | ||
| Q2 25 | -11.2% | 9.2% | ||
| Q1 25 | -231.2% | 8.9% | ||
| Q4 24 | 0.1% | 9.7% | ||
| Q3 24 | -21.9% | 12.2% | ||
| Q2 24 | -12.7% | 7.9% | ||
| Q1 24 | -19.1% | -34.7% |
| Q4 25 | $-0.06 | $0.07 | ||
| Q3 25 | $-0.03 | $0.05 | ||
| Q2 25 | $-0.05 | $0.06 | ||
| Q1 25 | $-1.14 | $0.05 | ||
| Q4 24 | $0.01 | $0.06 | ||
| Q3 24 | $-0.11 | $0.07 | ||
| Q2 24 | $-0.07 | $0.05 | ||
| Q1 24 | $-0.11 | $-0.14 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $8.6M | $28.6M |
| Total DebtLower is stronger | $35.9M | — |
| Stockholders' EquityBook value | $13.7M | $164.2M |
| Total Assets | $80.1M | $1.5B |
| Debt / EquityLower = less leverage | 2.61× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $8.6M | $28.6M | ||
| Q3 25 | $6.8M | $32.8M | ||
| Q2 25 | $7.4M | $34.2M | ||
| Q1 25 | $5.5M | $29.4M | ||
| Q4 24 | $4.1M | $25.3M | ||
| Q3 24 | $4.6M | $31.0M | ||
| Q2 24 | $4.0M | $27.8M | ||
| Q1 24 | $4.3M | $23.6M |
| Q4 25 | $35.9M | — | ||
| Q3 25 | $34.0M | — | ||
| Q2 25 | $34.9M | — | ||
| Q1 25 | $36.4M | — | ||
| Q4 24 | $37.0M | — | ||
| Q3 24 | $34.9M | — | ||
| Q2 24 | $35.7M | — | ||
| Q1 24 | $35.6M | — |
| Q4 25 | $13.7M | $164.2M | ||
| Q3 25 | $14.1M | $163.5M | ||
| Q2 25 | $15.7M | $162.0M | ||
| Q1 25 | $14.8M | $160.0M | ||
| Q4 24 | $63.3M | $158.3M | ||
| Q3 24 | $65.3M | $160.8M | ||
| Q2 24 | $67.2M | $155.9M | ||
| Q1 24 | $68.8M | $155.6M |
| Q4 25 | $80.1M | $1.5B | ||
| Q3 25 | $78.0M | $1.5B | ||
| Q2 25 | $80.1M | $1.5B | ||
| Q1 25 | $79.8M | $1.5B | ||
| Q4 24 | $126.6M | $1.5B | ||
| Q3 24 | $131.2M | $1.5B | ||
| Q2 24 | $128.9M | $1.5B | ||
| Q1 24 | $133.2M | $1.5B |
| Q4 25 | 2.61× | — | ||
| Q3 25 | 2.41× | — | ||
| Q2 25 | 2.22× | — | ||
| Q1 25 | 2.45× | — | ||
| Q4 24 | 0.58× | — | ||
| Q3 24 | 0.53× | — | ||
| Q2 24 | 0.53× | — | ||
| Q1 24 | 0.52× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-96.0K | $-506.0K |
| Free Cash FlowOCF − Capex | $-545.0K | $-736.0K |
| FCF MarginFCF / Revenue | -2.3% | -5.2% |
| Capex IntensityCapex / Revenue | 1.9% | 1.6% |
| Cash ConversionOCF / Net Profit | — | -0.37× |
| TTM Free Cash FlowTrailing 4 quarters | $5.5M | $20.4M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-96.0K | $-506.0K | ||
| Q3 25 | $1.1M | $16.8M | ||
| Q2 25 | $2.8M | $-697.0K | ||
| Q1 25 | $3.0M | $8.3M | ||
| Q4 24 | $1.7M | $2.2M | ||
| Q3 24 | $-842.0K | $764.0K | ||
| Q2 24 | $-846.0K | $5.4M | ||
| Q1 24 | $1.4M | $12.8M |
| Q4 25 | $-545.0K | $-736.0K | ||
| Q3 25 | $877.0K | $16.4M | ||
| Q2 25 | $2.7M | $-773.0K | ||
| Q1 25 | $2.5M | $5.6M | ||
| Q4 24 | $1.4M | $1.9M | ||
| Q3 24 | $-1.7M | $-1.4M | ||
| Q2 24 | $-1.7M | $5.3M | ||
| Q1 24 | $758.0K | $7.1M |
| Q4 25 | -2.3% | -5.2% | ||
| Q3 25 | 4.3% | 120.1% | ||
| Q2 25 | 13.0% | -5.8% | ||
| Q1 25 | 11.4% | 43.1% | ||
| Q4 24 | 5.8% | 15.0% | ||
| Q3 24 | -7.8% | -11.3% | ||
| Q2 24 | -7.2% | 43.7% | ||
| Q1 24 | 3.1% | 79.0% |
| Q4 25 | 1.9% | 1.6% | ||
| Q3 25 | 1.0% | 2.9% | ||
| Q2 25 | 0.4% | 0.6% | ||
| Q1 25 | 2.4% | 21.0% | ||
| Q4 24 | 1.2% | 2.4% | ||
| Q3 24 | 4.0% | 17.3% | ||
| Q2 24 | 3.5% | 0.9% | ||
| Q1 24 | 2.6% | 62.0% |
| Q4 25 | — | -0.37× | ||
| Q3 25 | — | 15.25× | ||
| Q2 25 | — | -0.57× | ||
| Q1 25 | — | 7.20× | ||
| Q4 24 | 95.83× | 1.79× | ||
| Q3 24 | — | 0.49× | ||
| Q2 24 | — | 5.63× | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
HBIO
| Instruments Equipment Software And Accessories | $21.6M | 91% |
| Service Maintenance And Warranty Contracts | $2.1M | 9% |
RVSB
Segment breakdown not available.
